Maitreya Medicare Limited Approves 7th AGM and Appoints Scrutinizer
The Board of Directors of Maitreya Medicare Limited, in a meeting held on August 24, 2026, approved several key decisions regarding the forthcoming 7th Annual General Meeting (AGM). The meeting focused on approving the AGM logistics, administrative requirements, and the appointment of a scrutinizer.The Board approved the holding of the company's 7th AGM, which is scheduled for Monday, September 21, 2026. The meeting will be conducted via Video Conferencing (VC) or other audiovisual means (OAVM), which will facilitate the e-voting facility for members.
During the board meeting, the directors' report along with its annexures was approved. Furthermore, the company approved the Notice of the AGM and all related business matters.
Key administrative actions approved by the Board included the appointment of Mr. Jaisal Mohatta, Partner of JDM and Associates LLP, Company Secretaries, to serve as the scrutinizer for the voting process of the 7th Annual General Meeting.
The Board also approved the closure of the Register of Members and Share Transfer Books for the period leading up to the AGM. This closing period is set from Tuesday, September 15, 2026, through Monday, September 21, 2026, both days inclusive.
MAITREYA Stock Price Movement
Today, Maitreya Medicare Limited stock closed flat, settling at ₹118.50 after recording no change from its prior close. The equity remained stable throughout the session, matching its base price trading across the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.